Iyer Smita S, Rojas Mauricio
Nutrition and Health Sciences Program, Atlanta, GA 30322, USA.
Expert Opin Biol Ther. 2008 May;8(5):569-81. doi: 10.1517/14712598.8.5.569.
Mesenchymal stem cells (MSC) are multipotent cells that can be isolated from the bone marrow and expanded in culture relatively easily. Culture-expanded MSC have been used in clinical settings to enhance hematopoietic stem cell engraftment in bone marrow transplant patients and in tissue regeneration therapy. More recently, the anti-inflammatory effects of MSC have generated a great deal of interest.
OBJECTIVE/METHODS: In this review we describe in vitro assays that have demonstrated how MSC regulate immune cell proliferation, differentiation and phenotype. We also highlight effector molecules produced by MSC that drive this function. In addition, we focus on animal models of lung injury, in which administration of MSC attenuates inflammation, and injury revealing a central role for MSC in mitigating pro-inflammatory networks and amplifying anti-inflammatory signals.
The discoveries described herein have contributed to the novel concept of MSC as a therapeutic modality in inflammatory diseases, including acute lung injury.
间充质干细胞(MSC)是多能细胞,可从骨髓中分离出来,并且相对容易在培养中扩增。培养扩增的MSC已用于临床环境,以增强骨髓移植患者的造血干细胞植入以及组织再生治疗。最近,MSC的抗炎作用引起了极大的兴趣。
目的/方法:在本综述中,我们描述了体外试验,这些试验证明了MSC如何调节免疫细胞的增殖、分化和表型。我们还强调了MSC产生的驱动该功能的效应分子。此外,我们重点关注肺损伤的动物模型,其中MSC的给药减轻了炎症,并且损伤揭示了MSC在减轻促炎网络和放大抗炎信号中的核心作用。
本文所述的发现促成了将MSC作为包括急性肺损伤在内的炎症性疾病的治疗方式的新概念。